Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving ...

Hyderabad-based Bharat Biotech International Ltd. has claimed that its oral cholera vaccine (OCV) under development, Hillchol ...

Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III ...

Longevity Health Holdings has secured a temporary reprieve from Nasdaq delisting, but the clock is ticking as the ...

Bharat Biotech's Hillchol OCV, effective against cholera serotypes, aims to provide affordable, accessible vaccines for ...

Bharat Biotech’s oral cholera vaccine, Hillchol, aims to ease a critical global shortfall, with the world currently lacking ...

Bharat Biotech to launch Hillchol, its oral cholera vaccine, amid a global shortage. With Phase III trials completed and 200M ...

Chandru Iyer, British Deputy High Commissioner to Karnataka and Kerala, on Wednesday said the impact of the India-United ...

High-impact workshop on ‘Biotechnology Applications for Crop Improvement’ highlights genetically modified and gene-edited ...

Data from the CDSCO reveals that numerous MSME pharmaceutical companies in India are producing substandard drugs, failing to ...

Learn about the battle against antimicrobial resistance (AMR) in India, the development of new antibiotics, and the urgent ...